293 related articles for article (PubMed ID: 12069688)
1. Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1.
Squires MS; Nixon PM; Cook SJ
Biochem J; 2002 Sep; 366(Pt 2):673-80. PubMed ID: 12069688
[TBL] [Abstract][Full Text] [Related]
2. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of peripheral benzodiazepine receptor ligand-induced apoptosis and cell cycle arrest of esophageal cancer cells by simultaneous inhibition of MAPK/ERK kinase.
Sutter AP; Maaser K; Gerst B; Krahn A; Zeitz M; Scherübl H
Biochem Pharmacol; 2004 May; 67(9):1701-10. PubMed ID: 15081869
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of thrombin-stimulated cell proliferation by ceramide is not through inhibition of extracellular signal-regulated protein kinase.
Guo YL; Peng M; Kang B; Williamson JR
Biochem Biophys Res Commun; 1997 Nov; 240(2):405-8. PubMed ID: 9388491
[TBL] [Abstract][Full Text] [Related]
5. Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1/2 pathway.
Ye M; Luo X; Li L; Shi Y; Tan M; Weng X; Li W; Liu J; Cao Y
Cancer Lett; 2007 Dec; 258(2):199-207. PubMed ID: 18029087
[TBL] [Abstract][Full Text] [Related]
6. The duration of nuclear extracellular signal-regulated kinase 1 and 2 signaling during cell cycle reentry distinguishes proliferation from apoptosis in response to asbestos.
Yuan Z; Taatjes DJ; Mossman BT; Heintz NH
Cancer Res; 2004 Sep; 64(18):6530-6. PubMed ID: 15374964
[TBL] [Abstract][Full Text] [Related]
7. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
8. Activation of extracellular signal-regulated kinases (ERK 44/42) by chlorpyrifos oxon in Chinese hamster ovary cells.
Bomser J; Casida JE
J Biochem Mol Toxicol; 2000; 14(6):346-53. PubMed ID: 11083088
[TBL] [Abstract][Full Text] [Related]
9. An anchorage-dependent signal distinct from p42/44 MAP kinase activation is required for cell cycle progression.
Le Gall M; Grall D; Chambard JC; Pouysségur J; Van Obberghen-Schilling E
Oncogene; 1998 Sep; 17(10):1271-7. PubMed ID: 9771970
[TBL] [Abstract][Full Text] [Related]
10. Activation of cyclin D1 expression by the ERK5 cascade.
Mulloy R; Salinas S; Philips A; Hipskind RA
Oncogene; 2003 Aug; 22(35):5387-98. PubMed ID: 12934098
[TBL] [Abstract][Full Text] [Related]
11. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
[TBL] [Abstract][Full Text] [Related]
13. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
14. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation.
Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3091-8. PubMed ID: 12202534
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress.
Cavanaugh JE; Jaumotte JD; Lakoski JM; Zigmond MJ
J Neurosci Res; 2006 Nov; 84(6):1367-75. PubMed ID: 16941494
[TBL] [Abstract][Full Text] [Related]
16. Tonic inhibitory role for cAMP in alpha(1a)-adrenergic receptor coupling to extracellular signal-regulated kinases 1/2.
Jiao X; Gonzalez-Cabrera PJ; Xiao L; Bradley ME; Abel PW; Jeffries WB
J Pharmacol Exp Ther; 2002 Oct; 303(1):247-56. PubMed ID: 12235258
[TBL] [Abstract][Full Text] [Related]
17. L-leucine increases [3H]-thymidine incorporation in chicken hepatocytes: involvement of the PKC, PI3K/Akt, ERK1/2, and mTOR signaling pathways.
Lee MY; Jo SD; Lee JH; Han HJ
J Cell Biochem; 2008 Dec; 105(6):1410-9. PubMed ID: 18980246
[TBL] [Abstract][Full Text] [Related]
18. Role of intracellular Ca2+ and calmodulin/MAP kinase kinase/extracellular signal-regulated protein kinase signalling pathway in the mitogenic and antimitogenic effect of nitric oxide in glia- and neurone-derived cell lines.
Meini A; Garcia JB; Pessina GP; Aldinucci C; Frosini M; Palmi M
Eur J Neurosci; 2006 Apr; 23(7):1690-700. PubMed ID: 16623825
[TBL] [Abstract][Full Text] [Related]
19. Src-dependent ERK5 and Src/EGFR-dependent ERK1/2 activation is required for cell proliferation by asbestos.
Scapoli L; Ramos-Nino ME; Martinelli M; Mossman BT
Oncogene; 2004 Jan; 23(3):805-13. PubMed ID: 14737115
[TBL] [Abstract][Full Text] [Related]
20. ERK1/2 and ERK5 have distinct roles in the regulation of brain-derived neurotrophic factor expression.
Su C; Underwood W; Rybalchenko N; Singh M
J Neurosci Res; 2011 Oct; 89(10):1542-50. PubMed ID: 21647938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
